JNCCN 360 – Ovarian – Gottfried E. Konecny, MD, on Targeting Folate Receptor Alpha in Ovarian Cancer

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn

Read the full article here

Source: jnccn360.org

Categories: Oncologists1, General Medicine News

Tags: OvarianCancer,JNCCN360,gyncsm

Tweets with this article

Journal of the @NCCN

Gottfried E. Konecny, MD, on Targeting Folate Receptor Alpha in #OvarianCancer: https://t.co/YjOCJ4uQuN #JNCCN360 #GynCSM https://t.co/sr0LRqvL2Q

Related Articles

JNCCN 360 – CLL/MCL – Relapsed or Refractory MCL: Brexucabtagene Autoleucel vs Allogeneic Transplant

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of…

Journal of the @NCCN May 5, 2025

JNCCN 360 – Ovarian – Final Results From ARIEL4: Rucaparib vs Chemotherapy for BRCA-Mutated Ovarian Cancer

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of…

Journal of the @NCCN May 5, 2025

JNCCN 360 – Ovarian – Oncogene UBE2J1 Tied to High-Grade Serous Ovarian Cancer

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of…

Journal of the @NCCN April 11, 2025

JNCCN 360 – CLL/MCL – Has Access to Multiple Agents Improved Survival in Older Patients With Mantle Cell Lymphoma?

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of…

Journal of the @NCCN April 10, 2025

JNCCN 360 – Non–Small Cell Lung Cancer – Advanced NSCLC: Targeting the CD73/Adenosine Pathway

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of…

Journal of the @NCCN April 10, 2025

JNCCN 360 – Advanced Skin Cancers – Efficacy of Antibody Clones in Diagnosing Merkel Cell Carcinoma

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of…

Journal of the @NCCN April 9, 2025

JNCCN

JNCCN

Journal of the @NCCN April 9, 2025

JNCCN 360 – Ovarian – Link Between Elevated Inflammatory Marker and Aggressive Ovarian Cancer Phenotypes?

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of…

Journal of the @NCCN April 4, 2025

JNCCN 360 – Breast – ER-Positive, HER2-Negative Advanced Breast Cancer: Camizestrant vs Fulvestrant

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of…

Journal of the @NCCN March 28, 2025

Potential targeted therapy for pediatric brain cancer identified by Dana-Farber/Boston Children’s team | Dana-Farber Cancer Institute

An international team of clinical collaborators, led by physician scientists from Dana-Farber Cancer Institute, performed a first-ever clinical test of the targeted therapy avapritinib in…

Dana-Farber March 20, 2025